id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0402-0032,FDA,FDA-2013-N-0402,Testimony from Association for Accessible Medicine,Other,Testimony,2017-05-17T04:00:00Z,2017,5,2017-05-17T04:00:00Z,,2017-05-17T14:02:11Z,,0,0,09000064825cd8d3
FDA-2013-N-0402-0029,FDA,FDA-2013-N-0402,Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Workshop; Request for Comments,Notice,Request for Comments,2017-03-14T04:00:00Z,2017,3,2017-03-14T04:00:00Z,2017-06-03T03:59:59Z,2017-06-03T13:00:35Z,2017-04981,0,0,0900006482505faf
FDA-2013-N-0402-0023,FDA,FDA-2013-N-0402,"Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives;
Public Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2016-03-09T05:00:00Z,2016,3,2016-03-09T05:00:00Z,,2024-11-12T05:59:06Z,2016-05221,1,0,0900006481eb47b7
FDA-2013-N-0402-0019,FDA,FDA-2013-N-0402,"Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives;
Public Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,2014-06-14T03:59:59Z,2014-06-15T00:48:15Z,2014-03986,0,0,09000064815c3a9e
FDA-2013-N-0402-0001,FDA,FDA-2013-N-0402,Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives Public Meeting; Request for Comments,Proposed Rule,Public Meeting,2013-05-09T04:00:00Z,2013,5,2013-05-09T04:00:00Z,2013-06-08T03:59:59Z,2014-03-06T17:14:13Z,2013-11007,0,0,09000064812d1dcc